Summit Global Investments

Position in LGND — Ligand Pharmaceuticals Inc

CIK 1697953 BOUNTIFUL, UT

Position in LGND

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$612,266

+$225,544 QoQ

Shares Held

1,937

0.0% QoQ

Ownership

0.010%

of shares outstanding

% of Portfolio

0.08%

of 13F equity value

Holder Rank

#233

of 411 holders

Holding Since

Mar 2023

11 quarters on record

Healthcare · as of Jun 30, 2026

Summit Global Investments holds $20,708,446 across 14 Biotechnology names. LGND ranks #8 (3.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	55,370	$6,276,743
2	REGN	Regeneron Pharmaceuticals, Inc.	7,506	$4,680,291
3	VRTX	Vertex Pharmaceuticals Inc / Ma	7,182	$3,567,514
4	BMRN	Biomarin Pharmaceutical Inc	32,667	$1,869,205
5	HRMY	Harmony Biosciences Holdings, Inc.	27,034	$984,307
6	KRYS	Krystal Biotech, Inc.	2,167	$805,408
7	PTCT	Ptc Therapeutics, Inc.	7,542	$615,200
8	LGND	Ligand Pharmaceuticals Inc This page	1,937	$612,266

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$612,266	1,937	0.0%	Shares	Sole	2026-08-03
2026-03-31	$386,722	1,937	-19.9%	Shares	Sole	2026-05-07
2025-12-31	$456,982	2,417	+67.6%	Shares	Sole	2026-02-18
2025-09-30	$255,435	1,442	-86.7%	Shares	Sole	2025-11-03
2025-03-31	$1,138,140	10,825	+145.0%	Shares	Sole	2025-04-07
2024-12-31	$473,388	4,418	-72.7%	Shares	Sole	2025-02-11
2024-03-31	$1,182,100	16,171	-16.6%	Shares	Sole	2024-04-29
2023-12-31	$1,385,333	19,397	-12.2%	Shares	Sole	2024-02-06
2023-09-30	$1,323,153	22,082	+80.5%	Shares	Sole	2023-10-16
2023-06-30	$882,287	12,237	+45.7%	Shares	Sole	2023-07-19
2023-03-31	$617,904	8,400	—	Shares	Sole	2023-05-04
No filing history on record for this holder in this stock.